Pfizer Inc

The momentum for this stock is not very good. Pfizer Inc has good value characteristics. The stock will provide you with a reasonable dividend income. Pfizer Inc is not very popular among insiders. Pfizer Inc is a mediocre stock to choose.
Log in to see more information.
Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specialize...
PFE Fundamental Data by TradingView

News

AGF Management Ltd. Boosts Holdings in Pfizer Inc. (NYSE:PFE)
AGF Management Ltd. Boosts Holdings in Pfizer Inc. (NYSE:PFE)

Zolmax AGF Management Ltd. boosted its position in Pfizer Inc. (NYSE:PFE - Free Report) by 6.7% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 1,223,841 shares of the biopharmaceutical...\n more…

Pfizer Inc. (NYSE:PFE) Shares Acquired by Angeles Wealth Management LLC
Pfizer Inc. (NYSE:PFE) Shares Acquired by Angeles Wealth Management LLC

Ticker Report Angeles Wealth Management LLC lifted its position in shares of Pfizer Inc. (NYSE:PFE - Free Report) by 24.0% in the 2nd quarter, according to its most recent filing with the Securities Exchange...\n more…

AGF Management Ltd. Acquires 76,464 Shares of Pfizer Inc. (NYSE:PFE)
AGF Management Ltd. Acquires 76,464 Shares of Pfizer Inc. (NYSE:PFE)

Ticker Report AGF Management Ltd. increased its holdings in Pfizer Inc. (NYSE:PFE - Free Report) by 6.7% during the 2nd quarter, according to the company in its most recent disclosure with the Securities &...\n more…

Comparing Pfizer (NYSE:PFE) & Kazia Therapeutics (NASDAQ:KZIA)
Comparing Pfizer (NYSE:PFE) & Kazia Therapeutics (NASDAQ:KZIA)

Ticker Report Pfizer (NYSE:PFE - Get Free Report) and Kazia Therapeutics (NASDAQ:KZIA - Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the...\n more…

Bristol Myers Stock Rises 16% in 3 Months: Buy, Sell or Hold?
Bristol Myers Stock Rises 16% in 3 Months: Buy, Sell or Hold?

Zacks Investment Research Bristol Myers Squibb Company BMY is experiencing a good run of late after touching a 52-week low of $39.35 on July 5. This short rally has given anxious investors a ray of hope. The biotech giant has...\n more…

Pfizer (PFE) Upgraded to Buy: What Does It Mean for the Stock?
Pfizer (PFE) Upgraded to Buy: What Does It Mean for the Stock?

Zacks Investment Research Pfizer (PFE) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the...\n more…